Hyperthermia
Local and Whole-Body Hyperthermia
Deep hyperthermia involves irradiating tumor tissues with radio waves, provoking the overheating of cancer cells, and is used in combination with other tumor treatment methods. The therapeutic use of heat is the oldest method of cancer treatment in medical history. As early as the 16th century BCE, papyrus scrolls described how the ancient Egyptians cauterized tumor tissues with hot iron objects. This was discovered in 1892 by American Egyptologist Edwin Smith in Luxor. These early attempts to destroy cancer cells involved using burning substances, objects, or heat, which is now known as tissue cauterization, a technique also used to stop bleeding.
Hyperthermia, by its nature, is an artificially induced fever and therapeutic use of heat applied to a specific body part (local hyperthermia) or the entire body (whole-body hyperthermia) under controlled conditions.
Fever therapy induces certain biological reactions in the body that affect the entire body, immune system, and specifically target cancer cells, making it highly beneficial for cancer treatment. Medically induced effects result in immune system modulation, leading to an “internal vaccination” against the tumor. During hyperthermia, to survive, tumor cells start to produce so-called heat shock proteins on their surface. Consequently, cancer cells become more visible and are more easily destroyed by the immune system. Hyperthermia is a highly effective treatment method when combined with other therapies, especially tumor irradiation, as one therapy method enhances the effect of the other. Tumor cells attempt to protect themselves from gamma rays by activating their own repair processes during irradiation and after ionizing radiation or even after several therapy sessions, which is one of the most unfavorable effects caused by irradiation. In the worst-case scenario, cancer cells become stronger, more resilient, and learn to cope with the treatment, becoming even more aggressive than before.
The heat generated by therapeutic hyperthermia makes cancer cells more sensitive to irradiation, similar to traditional methods using gamma rays. Hyperthermia blocks the repair processes in tumor cells, allowing irradiation to more effectively destroy these cells with less interference. Chemotherapy drugs used in oncology also become much more effective when combined with therapeutic hyperthermia, without increasing their unwanted side effects. Heat induces the so-called “enhancement effect”; consequently, platinum-based chemotherapy drugs have a much better and stronger effect when hyperthermia is applied compared to when the body temperature is normal. The effect of new immunotherapy agents called “checkpoint inhibitors (nivolumab, pembrolizumab, ipilimumab)” is also intensified with hyperthermia. Immune checkpoints are receptors located on the surface of T lymphocytes that regulate the immune response in the body. In other words, they serve as “instructors” for the immune system. Tumor cells can exploit these receptors to avoid being recognized and attacked by the immune system. These immune system-modulating drugs prevent cancer cells from binding to T lymphocyte checkpoint receptors, allowing the immune system to recognize and combat the degenerative cancer cells. The effect of these drugs is enhanced by the application of heat. Hyperthermia also improves local and general blood flow and microcirculation, facilitating the transport of these drugs to and into the cancer cells (tumor tissue perfusion), making the process much more efficient. Additionally, hyperthermia promotes the vitality of immune cells, which is a key benefit of fever—enhancing the body’s ability to fight inflammation and various pathogens.
Frequently Asked Questions